BioSpace News Archive

Neurelis Inc., is proud to take part in the 11th Annual Sofie’s Journey Epilepsy Awareness Day and Education Expo at Disneyland Resort (EADDL), the largest, worldwide epilepsy community gathering of the year.

Rapport Therapeutics, Inc. today announced the appointment of industry veteran Troy Ignelzi as Chief Financial Officer, effective November 1, 2023.

Vect-Horus, a privately held biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced it has entered into a global license agreement with Novo Nordisk A/S.

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS) released highlights from a clinical update event held today, October 30, 2023, in conjunction with the European School of Haematology (ESH) 6th International Conference: Acute Myeloid Leukemia “Molecular and Translational”: Advances in Biology and Treatment, being held in Estoril, Portugal (the “ESH 2023 Conference”).

The American Diabetes Association®, a sponsor of the 2023 Magic City Classic, and Genentech, anchor partner of the ADA’s Health Equity Now® program, launched the Eye Pledge to Fight Diabetes.

NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone”), a pioneering biotechnology company, is thrilled to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan-Drug Designation (ODD) for its ExoPTEN therapy, recognizing the potential of this groundbreaking regenerative therapy for acute spinal cord injury, a condition where effective treatments are limitedi.

The Cancer Research Institute has awarded Ananda Goldrath, Ph.D., Executive Vice President and Director of the Allen Institute for Immunology, the 2023 Frederick W. Alt Award.

Vernal Biosciences, a leading Contract Development and Manufacturing Organization specializing in mRNA and LNP manufacturing, proudly announces its participation in the 11th International mRNA Health Conference held in Berlin.

Nextech, a complete healthcare technology solution for specialty providers, is proud to announce its significant growth in market share over the past year, with the addition of more than 250 ophthalmology practices and 1,000 eye care providers to its network.

Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), today announced their participation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) occurring November 1-5, 2023 in San Diego, CA.